The NDA for LAR will evidently be a standard (10-month) rather than a priority review: <a href="http://finance.yahoo.com/news/Exenatide-Once-Weekly-New-prnews-15131272.html" rel="nofollow" target="_blank">http://finance.yahoo.com/news/Exenatide-Once-Weekly-New-prnews-15131272.html</a> Comments?